7-year follow-up after stereotactic ablative radiotherapy for patients with stage I non-small cell lung cancer: Results of a phase 2 clinical trial-Reference-Cited by-同舟云学术

7-year follow-up after stereotactic ablative radiotherapy for patients with stage I non-small cell lung cancer: Results of a phase 2 clinical trial

Published:2017-03-27 Issue:16 Volume:123 Page:3031-3039
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Sun Bing¹,Brooks Eric D.¹,Komaki Ritsuko U.¹,Liao Zhongxing¹,Jeter Melenda D.¹,McAleer Mary F.¹,Allen Pamela K.¹,Balter Peter A.²,Welsh James D.¹,O'Reilly Michael S¹,Gomez Daniel¹,Hahn Stephen M.¹,Roth Jack A.³,Mehran Reza J.³,Heymach John V.⁴,Chang Joe Y.¹^ORCID

Affiliation:

1. Department of Radiation Oncology; The University of Texas MD Anderson Cancer Center; Houston Texas

2. Department of Radiation Physics; The University of Texas MD Anderson Cancer Center; Houston Texas

3. Department of Thoracic and Cardiovascular Surgery; The University of Texas MD Anderson Cancer Center; Houston Texas

4. Department of Thoracic/Head and Neck Medical Oncology; The University of Texas MD Anderson Cancer Center; Houston Texas

Funder

National Cancer Institute

University of Texas MD Anderson Cancer Center

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference31 articles.

1. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials;Chang;Lancet Oncol.,2015

2. Stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer;Crabtree;J Thorac Cardiovasc Surg.,2010

3. Stage I-II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): outcomes of a propensity score-matched analysis;Verstegen;Ann Oncol.,2013

4. A propensity-matched analysis of wedge resection and stereotactic body radiotherapy for early stage lung cancer;Port;Ann Thorac Surg.,2014

5. Stereotactic ablative radiotherapy for centrally located early stage non-small-cell lung cancer: what we have learned;Chang;J Thorac Oncol.,2015

Cited by 130 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New diagnostic and nonsurgical local treatment modalities for early stage lung cancer;Lung Cancer;2024-10

2. Treatment patterns and survival outcomes in octogenarians with early-stage non-small cell lung cancer from 2011 to 2020: a SEER database analysis;2024-08-26

3. Stereotactic body radiation therapy for multiple lung cancers in a patient with six primary cancers: a case report;Journal of Medical Case Reports;2024-07-11

4. ERJ Advances: interventional bronchoscopy;European Respiratory Journal;2024-07

5. The dynamic duo: A narrative review on the synergy between stereotactic body radiotherapy and immunotherapy in lung cancer treatment (Review);Oncology Reports;2024-06-11